Hiding from Hep C? Dive in with experts Dr. Gina Simoncini, MD, MPH Associate Professor of Clinical Medicine at Temple University Hospital, & Dr. David Koren, PharmD, BCPS, AAHIVP, board-certified pharmacotherapy specialist and infectious diseases clinical pharmacist at Temple University Hospital. They walk us through a simplified approach on whom to screen, how to start antiviral therapy, what to follow up on, and how to navigate insurance waters along the way. Special thanks to Sarah Roberts and Jordana Kozupsky who wrote and produced this episode and the show notes!
Full show notes available at http://thecurbsiders.com/podcast
Join our mailing list and receive a PDF copy of our show notes every Monday. Rate us on iTunes, recommend a guest or topic and give feedback at
[email protected].
Time Stamps
00:00 Intro01:00 Guest bios03:00 Getting to know our guests05:35 Picks of the week10:05 Clinical case10:54 Diagnosing HCV12:00 ASCEND study13:14 Restrictions on HCV treatment15:17 Ordering and interpreting pre-treatment tests19:30 Prescribing medication22:00 Genotyping and drug resistance24:10 Patient counseling25:49 Understanding drug classes27:33 Drug interactions30:06 Multidisciplinary approach to treatment33:01 Follow-up36:47 Reinfection/cure rates39:35 Patient counseling revisited41:25 Side effects of treatment42:53 Screening44:02 Take home pointsTags: hepatitis, virus, hcv, direct-acting, antiviral, therapy, management, primary, care, liver, ultrasound, fibrosis, cirrhosis, side, effects, monitoring, hcc, hiv, infectious, disease, assistant, education, doctor, family, foam, foamed, health, hospitalist, hospital, internal, internist, nurse, meded, medicine,